Enhanced beta cell function after chronic treatment with the dipeptidyl peptidase-4 inhibitor Vildagliptin in an advanced age diet-induced obesity mouse model

被引：0
|
作者：
Omar, B. [1 ]
Vikman, J. [1 ]
Winzell, M. S. [1 ]
Ahren, B. [1 ]
机构：
[1] Lund Univ, S-22100 Lund, Sweden
来源：
DIABETOLOGIA | 2012年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
861
引用
收藏
页码：S355 / S356
页数：2
相关论文
共 37 条
  • [21] Dipeptidyl peptidase 4 inhibitor attenuates obesity-induced myocardial fibrosis by inhibiting tissue growth factor-beta and Smad2/3 pathways in high-fat diet-induced obesity rat model
    Ihm, Sang-Hyun
    Hong, Seul Ki
    Chang, Kiyuk
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : C26 - C26
  • [22] Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice
    Y. Takeda
    Y. Fujita
    J. Honjo
    T. Yanagimachi
    H. Sakagami
    Y. Takiyama
    Y. Makino
    A. Abiko
    T. J. Kieffer
    M. Haneda
    Diabetologia, 2012, 55 : 404 - 412
  • [23] Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice
    Takeda, Y.
    Fujita, Y.
    Honjo, J.
    Yanagimachi, T.
    Sakagami, H.
    Takiyama, Y.
    Makino, Y.
    Abiko, A.
    Kieffer, T. J.
    Haneda, M.
    DIABETOLOGIA, 2012, 55 (02) : 404 - 412
  • [24] Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic β-cell mass and function in a rodent model of type 2 diabetes
    Mu, James
    Woods, John
    Zhou, Yun-Ping
    Roy, Ranabir Sinha
    Li, Zhihua
    Zycband, Emanuel
    Feng, Yue
    Zhu, Lan
    Li, Cai
    Howard, Andrew D.
    Moller, David. E.
    Thornberry, Nancy A.
    Zhang, Bei B.
    DIABETES, 2006, 55 (06) : 1695 - 1704
  • [25] Dipeptidyl Peptidase-4 Inhibition Ameliorates Western Diet-Induced Hepatic Steatosis and Insulin Resistance Through Hepatic Lipid Remodeling and Modulation of Hepatic Mitochondrial Function
    Aroor, Annayya R.
    Habibi, Javad
    Ford, David A.
    Nistala, Ravi
    Lastra, Guido
    Manrique, Camila
    Dunham, Merlow M.
    Ford, Kaitlin D.
    Thyfault, John P.
    Parks, Elizabeth J.
    Sowers, James R.
    Rector, R. Scott
    DIABETES, 2015, 64 (06) : 1988 - 2001
  • [26] Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice
    Moritoh, Yusuke
    Takeuchi, Koji
    Asakawa, Tomoko
    Kataoka, Osamu
    Odaka, Hiroyuki
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 588 (2-3) : 325 - 332
  • [27] Beta cell-derived C3 is protective in a mouse model of diet-induced obesity and diabetes
    Colineau, Lucie
    Slaby, Julia
    Mckay, Marina
    Fex, Malin
    King, Ben
    Blom, Anna
    IMMUNOBIOLOGY, 2023, 228 (05) : 94 - 95
  • [28] Dipeptidyl peptidase 4 inhibitor attenuates obesity-induced myocardial fibrosis through inhibition of tissue growth factor-beta1 pathway in a high fat diet induced obesity rat model
    Ihm, S. -H.
    Hong, S. K.
    Chang, K. Y.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1343 - 1343
  • [29] Dipeptidyl peptidase 4 inhibitor attenuates obesity-induced myocardial fibrosis by inhibiting transforming growth factor-β1 and Smad2/3 pathways in high-fat diet-induced obesity rat model
    Hong, Seul-Ki
    Choo, Eun-Ho
    Ihm, Sang-Hyun
    Chang, Kiyuk
    Seung, Ki-Bae
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2017, 76 : 42 - 55
  • [30] Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Sitagliptin Improved Beta-Cell Function and Prevented a Conversion Rate to MTG and DM2 in Metformin Intolerant PCOS with High Metabolic Risk
    Ferjan, Simona
    Jensterle, Mojca
    Janez, Andrej
    DIABETES, 2017, 66 : A563 - A563
1234